Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jason Haffizulla"'
Autor:
Nathalie Charland, Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Sonia Trépanier, Karen Hager, Julia Jiang-Wright, Judith Atkins, Pooja Saxena, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, François Roman, Robbert Van Der Most, Maria Angeles Ceregido, Marc Dionne, Guy Tellier, Jean-Sébastien Gauthier, Brandon Essink, Michael Libman, Jason Haffizulla, André Fréchette, Marc-André D’Aoust, Nathalie Landry, Brian J. Ward
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-13 (2022)
Abstract The rapid spread of SARS-CoV-2 continues to impact humanity on a global scale with rising total morbidity and mortality. Despite the development of several effective vaccines, new products are needed to supply ongoing demand and to fight var
Externí odkaz:
https://doaj.org/article/b6a4cc5cfcb64d00803666e2639e3ffb
Autor:
Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Nathalie Charland, Sonia Trépanier, Karen Hager, Julia Jiang-Wright, Judith Atkins, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, François Roman, Robbert Van Der Most, Maria Angeles Ceregido, Marc Dionne, Guy Tellier, Jean-Sébastien Gauthier, Brandon Essink, Michael Libman, Jason Haffizulla, André Fréchette, Marc-André D’Aoust, Nathalie Landry, Brian J. Ward
The rapid spread of SARS-CoV-2 continues to impact humanity on a global scale with rising total morbidity and mortality. Despite the development of several effective vaccines, new products are needed to supply ongoing demand and the needs of specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df6b201e4d79fbb42ddadc8142f064a
https://doi.org/10.1101/2021.05.14.21257248
https://doi.org/10.1101/2021.05.14.21257248
Autor:
Jason, Haffizulla, Aaron, Hartman, Melanie, Hoppers, Harvey, Resnick, Steve, Samudrala, Christine, Ginocchio, Matthew, Bardin, Jean-François, Rossignol, Gary, Yeoman
Publikováno v:
The Lancet. Infectious diseases. 14(7)
Summary Background Influenza is an important cause of morbidity and mortality worldwide. Treatment options are scarce, and new drugs with novel mechanisms of action are needed. We aimed to assess the efficacy and safety of nitazoxanide, a thiazolide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc1b286233b2ea3e5435489a6047f64
https://pubmed.ncbi.nlm.nih.gov/24852377
https://pubmed.ncbi.nlm.nih.gov/24852377